The nuclear import of the nuclear factor of activated T cells (NFAT)-family transcription factors is initiated by the protein phosphatase calcineurin. Here we identify a regulatory region of NFAT1, N terminal to the DNAbinding domain, that controls nuclear import of NFAT1. The regulatory region of NFAT1 binds directly to calcineurin, is a substrate for calcineurin in vitro, and shows regulated subcellular localization identical to that of full-length NFAT1. The corresponding region of NFATc likewise binds calcineurin, suggesting that the efficient activation of NFAT1 and NFATc by calcineurin reflects a specific targeting of the phosphatase to these proteins. The presence in other NFATfamily transcription factors of several sequence motifs from the regulatory region of NFAT1, including its probable nuclear localization sequence, indicates that a conserved protein domain may control nuclear import of all NFAT proteins. NFAT1 (nuclear factor of activated T cells 1) (previously termed NFATp) (1-3) is a member of the NFAT family of transcription factors, proteins that play a key role in the regulation of cytokine gene transcription during the immune response (4-6). Other members of the NFAT family include NFATc (7), NFATx/NFAT4 (8-10), and NFAT3 (9). NFATfamily proteins show strong sequence conservation in their DNA-binding domains (8-12), and moderate sequence conservation in a second region located immediately N terminal to the DNA-binding domain (54).
NFAT1 (nuclear factor of activated T cells 1) (previously termed NFATp) (1-3) is a member of the NFAT family of transcription factors, proteins that play a key role in the regulation of cytokine gene transcription during the immune response (4) (5) (6) . Other members of the NFAT family include NFATc (7) , NFATx/NFAT4 (8) (9) (10) , and NFAT3 (9) . NFATfamily proteins show strong sequence conservation in their DNA-binding domains (8) (9) (10) (11) (12) , and moderate sequence conservation in a second region located immediately N terminal to the DNA-binding domain (54) .
A central feature of the regulation of NFAT-family proteins is their pronounced sensitivity to the immunosuppressive drugs cyclosporin A (CsA) and FK506 (13, 14) . These drugs, which are potent inhibitors of cytokine gene transcription in activated T cells, B cells, mast cells, and NK cells (15) (16) (17) (18) , act by binding to intracellular immunophilins and inhibiting the activity of the calmodulin-dependent phosphatase calcineurin (19, 20) . Inhibition of calcineurin with the immunosuppressive drugs prevents the appearance of NFAT DNA-binding activity in the cell nucleus when T cells and other immune system cells are stimulated (1, 18, (21) (22) (23) (24) (25) (26) , and blocks NFAT-dependent reporter gene transcription (21, 23, 25) . Conversely, overexpression of calcineurin or expression of constitutively active calcineurin partially replaces the calcium requirement for NEAT-dependent transcriptional activation in T cells (17, (27) (28) (29) .
Detailed analysis of one NFAT-family protein, NFAT1, has provided more insight into the molecular mechanisms by which calcineurin regulates NFAT activity. NFAT1 is present in the cytoplasm of resting T cells and translocates into the nucleus in response to stimulation with ionomycin, antigen, or anti-CD3 (30, 55) . Early events in the activation of NFAT1 are its rapid dephosphorylation, an increase in its affinity for NFAT sites in DNA, and its nuclear import (30) . Each of these three hallmarks of activation is dependent on calcineurin, since each is blocked by CsA or FK506 (30) . Here we present evidence suggesting that the close control of NFAT1 activation by the calcium/calcineurin pathway reflects a protein-protein interaction that targets calcineurin to NFAT1.
MATERIALS AND METHODS
cDNA Constructs. The cDNAs encoding murine NFAT1, human NFAT1(1-415), murine NFAT1(399-927), and murine NFAT1(398-694) were subcloned into pEFTAG, a derivative of the expression vector pEF-BOS (31) that has been modified to encode an influenza hemagglutinin (HA) peptide at the N terminus of the expressed proteins. Details of the subcloning steps are available from the authors. Murine NFAT1(398-694) is the DNA-binding domain that has been expressed in bacteria as the hexahistidine-tagged protein NFATpXS(1-297) (11) .
Bacterial expression plasmids for the glutathione Stransferase (GST) fusion proteins GST-NFAT1(1-415) and GST-NFATc(1-418) were made by subcloning the corresponding regions of human NFAT1 and NFATc cDNAs into pGEX2T.
Site-Directed Mutagenesis. Single-stranded plasmid DNA containing uracil (32) was prepared from a pLGP3 vector (33) with the murine NFAT1 cDNA insert. Site-directed mutagenesis (32) using the oligonucleotides 5'-TCACCCGGTGC-CGCTGCAGCTCATTCGTGCGCA-3' and 5 '-GTCAT-CAACGGAGCTGCAGCCACTAGTCAGCCACAGCA-3' was carried out to replace the codons for KRR or KRKR, respectively, and plasmids carrying the mutant sequences were identified by DNA sequencing. EcoNI-BglII and MluI-HindIII fragments, carrying respectively the region encoding the KRR to AAA substitution and the region encoding the KRKR to AAAT substitution, were used to replace the corresponding fragments of pBluescript-mNFAT1-C (C.L., unpublished work). TheAatII-SalI fragments of the resulting plasmids were subcloned into pEFTAG for expression in T cells. The sequence of the entire fragment subcloned from the pLGP3 vector was verified by DNA sequencing by the dideoxy chaintermination method (34) .
Immunocytochemical Localization of Recombinant Proteins. Plasmids were introduced into Jurkat cells by electroporation, and into clone 7W2 cells by the DEAE-dextran method. Two days later cells in medium at 37°C were treated Proc. Natl. Acad. Sci. USA 93 (1996) as indicated, then fixed and stained with the anti-HA tag antibody (12CA5; Boehringer Mannheim) and Cy-3-labeled donkey anti-mouse IgG (Jackson ImmunoResearch). Transient expression of the tagged protein was detectable in 1-5% of human Jurkat T cells and in 0.2-2% of murine clone 7W2 cells. At least three independent experiments were analyzed for each recombinant protein.
In Vitro Dephosphorylation. Unstimulated Ar-5 T cells were lysed in RIPA buffer (30) supplemented with protease inhibitors and phosphatase inhibitors, and NFAT1 was immunoprecipitated. Immunoprecipitates were resuspended in calcineurin assay buffer (50 mM Hepes, pH 7.4/2 mM MnCl2/0.5 mM EDTA/15 mM 2-mercaptoethanol) with 0.1 mg/ml BSA, 20 ,uM leupeptin, and 10 ,ug/ml aprotinin, and incubated at 30°C for 10 min with 100 nM calcineurin (35) and 500 nM purified calmodulin. SDS lysates were prepared as described (30) . The samples were examined by Western blotting with anti-NFAT1 antiserum (anti-67.1) (30, 36) .
Expression constructs encoding HA-tagged NFAT1 or NFAT1(1-415) were introduced into COS cells using DEAEdextran combined with adenovirus (37 supplemented with CaCl2 has not been determined directly, but it will necessarily be much lower than 1 mM, given the presence of F-and other anions in the binding buffer.) Cell lysates or purified calcineurin (Sigma, 0.3 ,ug in 0.5 ml binding buffer, supplemented with 1 mM CaCl2 or 5 mM EGTA) were incubated with 10 ,ul (in some experiments, 15 ,lI) glutathioneSepharose with bound GST-NFAT1(1-415), GST-NFATc(1-418), GST, or GST-LSF (38), or with glutathione-Sepharose or Sepharose alone at 4°C for 1 h or 1.5 h. The resin was washed, and proteins were eluted by boiling in Laemmli reducing buffer and analyzed by Western blotting using anti-calcineurin antiserum. The anti-calcineurin is a rabbit antiserum raised against the peptide YITSFEEAKGLDRINERMPPRRDAMPSD, corresponding to the auto-inhibitory domain of the calcineurin A chain (C.L., unpublished).
RESULTS
The Region NFAT1(1-415) Controls Nuclear Import of NFAT1. To define the region of NFAT1 that renders its cytoplasmic/nuclear localization sensitive to calcineurin, we have expressed NFAT1 and specific truncated NFAT1 proteins in T cells. The DNA-binding domain of NFAT1 has been identified (11) HA-tagged recombinant NFAT1 shows correctly regulated intracellular localization in human Jurkat T cells. The protein is restricted to the cytoplasm in unstimulated cells, it translocates to the cell nucleus on stimulation with ionomycin, and its translocation is completely prevented by pretreatment with CsA ( Fig. 1) (Fig. 24) . The mutation KRR > AAA in NFAT1 prevents nuclear translocation of the full-length recombinant prottin in response to stimulation with ionomycin (Fig. 2B) . Another basic motif conserved in NFATfamily proteins, the sequence KRKR located at residues 666-669 in the Rel similarity domain of murine NFAT1, has been proposed as an NLS (8, 10, 40, 41) . Replacing KRKR with the sequence AAAT in NFAT1 has no effect on the cytoplasmic localization of the full-length protein in unstimulated cells, or on its nuclear localization in stimulated cells (Fig. 2B) .
These findings are consistent with a role for the N-terminal region of NFAT1 in controlling the intracellular localization of the protein. The simplest interpretation is that the KRR sequence at residues 253-255 forms part of a functional NLS, and that activation leads to unmasking of the NLS through a conformational change or through dissociation of a proteinprotein complex. In contrast to the requirement for the KRR sequence in the N-terminal region, the KRKR sequence at residues 666-669 in the Rel similarity region of NFAT1 is not necessary and is not by itself sufficient for nuclear import of full-length NFAT1. Because estimates of nuclear pore size (42, 43) and data for bovine serum albumin (44) We have therefore examined dephosphorylation of T cell NFAT1 under carefully defined conditions. In vitro dephosphorylation of T cell NFAT1 with calcineurin in cell extracts or in immunoprecipitates causes NFAT1 to migrate at a position very similar to that of NFAT1 from ionomycinstimulated T cells (Fig. 3A, lanes 2 and 4, and data not shown) . The change in mobility results from dephosphorylation, and not simply from proteolytic cleavage, because it is prevented by inclusion of the general phosphatase inhibitor sodium pyrophosphate in the incubation (lane 5). From these results it is plausible that the same subset of sites is dephosphorylated in vitro by calcineurin and in cells, although identification of the individual sites will be required to establish this point.
We have extended this approach to examine the dephosphorylation of NFAT1(1-415) by calcineurin, using recombinant NFAT1(1-415) expressed in COS cells. Control experiments established that full-length recombinant NFAT1 from COS cells migrates slightly slower than T cell NFAT1 on SDS/polyacrylamide gels, consistent with the presence of the HA-tag peptide, and undergoes an increase in mobility similar to that of T cell NFAT1 on dephosphorylation by calcineurin in vitro (Fig. 3B and data not shown) . NFAT1(1-415) expressed and phosphorylated in COS cells is also dephosphorylated by calcineurin (Fig. 3B) . The dephosphorylation is an effect of calcineurin, because it does not occur in extracts incubated without addition of calcineurin, and it is blocked by CsA-cyclophilin and by FK506-FKBP12, specific inhibitors of calcineurin, and by the general phosphatase inhibitor sodium pyrophosphate. It is not blocked by the protein phosphatase inhibitor okadaic acid, which is ineffective against calcineurin. The results indicate that some or all of the sites in NFAT1 dephosphorylated by calcineurin are within the N-terminal region NFAT1(1-415).
NFAT1(1-415) Binds Calcineurin. Because NFAT1(1-415) is a substrate for calcineurin in vitro, and because kinases and phosphatases in many cases interact detectably with their substrates or are tethered to their substrates by a targeting subunit, we have tested whether the N-terminal region of NFAT1 could interact with the calcineurin in cell lysates. A GST-NFAT1(1-415) fusion protein specifically binds calcineurin present in T cell extracts, and causes its retention on glutathione-Sepharose (Fig. 4A) . Binding is inhibited in the presence of EGTA, indicating a requirement for Ca2>. There is no binding of calcineurin to GST itself, to a fusion protein of GST with LSF [an unrelated DNA-binding protein (38) ], or to glutathione-Sepharose or Sepharose alone, even though equal amounts of calcineurin are present in each case (Fig. 4A,  lower) . In further experiments, GST-NFAT1(1-415), but not GST, specifically bound purified calcineurin (Fig. 4B) , demonstrating that the interaction of calcineurin with GST-NFAT1(1-415) is a direct protein-protein interaction, and does not require other proteins present in cell lysates. As the NFAT1 protein expressed in bacteria is not likely to be phosphorylated, the calcineurin-NFAT1 interaction apparently involves determinants other than simple recognition of a phosphopeptide substrate.
The other NFAT-family protein prominent in mature immune system cells is NFATc. We have expressed the Nterminal region of NFATc in bacteria as a GST-NFATc(1-418) fusion protein, and demonstrated its ability to bind calcineurin in the same assay (Fig. 4C) . NFAT1 and NFATc differ substantially in the N-terminal 100 residues, but have common sequence motifs in the region represented by human NFAT1(110-415), suggesting that the interaction of NFAT1 with calcineurin involves this portion of the protein.
DISCUSSION
We have identified a calcineurin-responsive regulatory region in NFAT1 that controls the subcellular localization of NFAT1 in resting and activated T cells. This regulatory region is distinct from the DNA-binding domain of NFAT1, but includes the NFAT homology region of -300 residues immediately N terminal to the DNA-binding domain. Within the NFAT homology region, the KRR (or KRK) candidate NLS and certain other protein motifs are conserved in all NFAT proteins, raising the possibility that the NFAT homology region is a conserved regulatory domain that controls the intracellular localization of NFAT-family proteins in response to the calcium/calcineurin signaling pathway or other signaling pathways.
The binding of calcineurin to the N-terminal portion of NFAT1 and NFATc, and evidence from a different experimental approach that calcineurin can form a complex with phosphorylated NFAT1 extracted from T cells (46, 47) , is reminiscent of known targeting interactions involving protein phosphatases. The preferential localization of calcineurin and other serine/threonine phosphatases at specific intracellular locations has been documented (48) (49) (50) , and in a few cases the protein-protein interactions that target the phosphatases have been identified. For example, the catalytic subunit of protein phosphatase 1, which shows relatively little substrate specificity in vitro, is directed toward one set of substrates, the enzymes involved in glycogen metabolism, by a glycogen-binding targeting subunit (49) . Targeting subunits directing protein phosphatase 1 to myofibrils and to sarcoplasmic reticulum have also been identified (49) . A protein phosphatase 1-retinoblastoma protein interaction has been detected, and may serve either to direct the phosphatase to retinoblastoma protein as a physiological substrate or to target protein phosphatase 1 to specific nuclear sites (51) . Calcineurin itself is directed to the IP3 receptor and to the ryanodine receptor by an interaction with FKBP12 (52) . And, in neurons, the A-kinase anchor protein AKAP-79 binds both calcineurin and protein kinase A (53), conferring subsynaptic localization and positioning calcineurin to act on its substrate the PKA subunit RII and on other phosphoprotein substrates generated by activation of protein kinase A.
Calcineurin-NFAT1 and calcineurin-NFATc interactions could position calcineurin to dephosphorylate sites on NFAT1, on NFATc, or on associated proteins. One possibility is that the efficient activation of NFAT is ensured by the presence of a preformed calcineurin-NFAT complex in the resting cell. Alternatively, even a transient calcineurin-NFAT interaction could serve to enhance the rate of dephosphorylation, to stabilize the enzyme-substrate complex sufficiently to allow dephosphorylation of NFAT1 at multiple sites, or to ensure that NFAT1 is not rephosphorylated before its interaction with NLS-binding proteins. Whether there is in fact a preformed calcineurin-NFAT1 complex will be determined by the Kd for the calcineurin-NFAT1 binding reaction at resting cytoplasmic Ca2+ concentrations, by the intracellular concentration of free calcineurin, and conceivably by the presence of other cellular proteins that stabilize the complex.
There are practical grounds for more detailed study of the calcineurin-NFAT interaction. The nephrotoxic and neurotoxic effects of current immunosuppressive drugs correlate with their ability to inhibit calcineurin, but it is plausible that substrates other than NFAT are the principal physiological targets of calcineurin in kidney and brain. In that case, compounds that interfere selectively with the calcineurin-NFAT1 and calcineurin-NFATc interactions, but that do not inhibit the enzymatic activity of calcineurin against other substrates, would lack the toxic effects of CsA and FK506. Such compounds would be useful not only in the management of transplant rejection, but also in the treatment of asthma, allergy, inflammation, and autoimmune diseases where the toxicity of CsA and FK506 precludes their routine use.
